"I have been on Ibrutinib since feb 2013... I have been in clinical remission for 8 months + .
I
was in a clinical study for the first 2 years and at the end of that
time I was asked to sign up for another study that lasts another 2
years...... This time I will only see the MD every 6 months with a CT
Scan every year.but I will have to take 3 pills a day ( Compliments of
the study)...I signed up for the additional 2 years but after 6 months
of it with all my other problems (apnea, CAD, hypothyroidism ,
Hypertension , Pulmonary hypertension , knees that need to be replaced
but will never be .) I am obviously having second thoughts.
Is
Ibrutinib a drug that you are on for life?? The fact that I am getting
it for free is a strong factor to continue on the trial , but the
fatigue and strange other things that are popping up are telling me to
drop out of the trial ...I feel that it is making what little life I
have left is not the quality of life that I want and Ibrutinib may be
causing some of these problems...Today I am going to ask for a 2 month
holiday from the study see if the fatigue and other problems go away.
I need advice here as to what the drug is designed to do once in remission.. And what would you do?"
Libellés
LLC
(100)
LLC 11q-
(2)
LLC anticorp monoclonal
(4)
LLC avis sur les traitements
(2)
LLC consultation mon cas
(11)
LLC Définition
(2)
LLC Dr Terry Hamblin
(13)
LLC éléments analysés
(5)
LLC Essais Cliniques
(11)
LLC étude d'un point
(4)
LLC exemple de traitement
(1)
LLC Genetique
(2)
LLC groupe de patients
(1)
LLC immunodepression
(1)
LLC les bases
(1)
LLC Mes Analyses
(6)
LLC molecule
(16)
LLC Molecule Arzerra
(1)
LLC Molecule Cirmtuzumab
(1)
LLC Molecule Gaziva
(1)
LLC molecule Ibrutinib
(3)
LLC molecule idelalisib
(2)
LLC MonTraitement1
(9)
LLC revue du net
(1)
LLC statistique survie
(8)
LLC témoignage après chimio
(1)
LLC témoignage chimio
(4)
LLC TH But du traitement
(1)
LLC TH Conseils
(1)
LLC TH CT scan
(1)
LLC TH Etudes
(1)
LLC TH Greffe
(1)
LLC TH Immunodeficience
(2)
LLC TH Les Traitements
(1)
LLC TH MBR
(1)
LLC TH Molecules
(1)
LLC TH Pronostiqueurs
(1)
LLC Traitement
(10)
LLC video
(1)
Traitement
(1)